Methods of treating liver disease using indane acetic acid derivatives
A post-treatment, hepatitis C virus technology, applied in the direction of pharmaceutical formulas, drug combinations, medical preparations containing active ingredients, etc., can solve problems such as permanent damage to the liver, scars, liver cirrhosis, etc.
Inactive Publication Date: 2018-01-02
T3D THERAPEUTICS INC
View PDF17 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
However, NASH can be serious and can lead to cirrhosis of the liver, in which the liver is permanently damaged and scarred, no longer able to function properly
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
example 1
[0235] [(1S)-5-Hydroxy-2,3-dihydro-1H-inden-1-yl]ethyl acetate
[0236]
[0237] Prepared from 5-methoxyindanone in six steps as described in US68283335.
example 2
[0239] 2-[5-Ethyl-2-(4-methoxyphenyl)-1,3-oxazol-4-yl]ethanol
[0240]
[0241] Prepared from L-aspartic acid β-methyl ester hydrochloride, 4-methoxybenzoyl chloride and propionic anhydride as generally described in US68283335.
example 3
[0243] 2-[2-(4-Methoxyphenyl)-5-methyl-1,3-oxazol-4-yl]ethanol
[0244]
[0245] Prepared from L-aspartic acid β-methyl ester hydrochloride, 4-methoxybenzoyl chloride and acetic anhydride as generally described in US Patent 6,828,335.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
This invention describes the use of indane acetic acid derivatives which are dual PPAR delta / gamma agonists for the treatment of liver diseases including one or more of the following: NAFLD (Non Alcoholic Fatty Liver Disease), NASH (Non Alcoholic Steatohepatitis), Farber's Disease, ACLF (Acute-on-Chronic Liver Failure), CLF (Chronic Liver Failure), POLT-HCV-SVR (Post-Orthotopic Liver Transplantdue to Hepatitis C Virus infection after Sustained Viral Response following anti-HCV therapy), Alagille syndrome, PFIC (Progressive Familial Intrahepatic Cholestasis), PBC (Primary Biliary Cirrhosis),Primary Sclerosing Cholangitis, ADPCLD (Autosomal Dominant Polycystic Liver Disease), Treatment of liver transplant patients with reestablished fibrosis, CESD (Cholesteryl Ester Storage Disease), SHTG (Severe Hypertriglyceridemia), HoFH (Homozygous Familial Hypercholesterolemia), HE (Hepatic Encephalopathy), or Alcoholic Liver Disease.
Description
[0001] Cross References to Related Applications [0002] This application claims priority to US Provisional Application No. 62 / 138,698, filed March 26, 2015, which is incorporated by reference in its entirety. [0003] Copyright Notice [0004] Portions of the disclosure of this patent contain copyrighted material. The copyright owner has no objection to the reproduction by anyone of any patent document or patent disclosure, as it appears in the Patent and Trademark Office patent file or records, but otherwise reserves all copyrights. technical field [0005] The present invention relates to the use of indane acetic acid and derivatives thereof as dual PPARδ and γ agonists in the treatment of the following liver diseases: NAFLD (nonalcoholic fatty liver disease), NASH (nonalcoholic steatohepatitis), Farber disease, ACLF ( Acute-on-chronic liver failure), CLF (chronic liver failure), POLT-HCV-SVR (orthotopic liver transplantation after hepatitis C virus infection after sus...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/535
CPCA61K31/426A61K31/421A61P1/16A61K45/06
Inventor 约翰·罗伯特·迪兹伯里
Owner T3D THERAPEUTICS INC
PatSnap Eureka turns technology decisions into work you can execute. Powered by our Innovation Knowledge Graph, it runs expert workflows across engineering, life sciences, materials and intellectual property. Get your review-ready output in minutes.
